Yasumasa Kakei

Dr. Yasumasa Kakei

Clinical and Translational Research Center, Kobe University Hospital, Kōbe, Hyōgo, Japan
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
THTakumi Hasegawa
Takumi Hasegawa
SRS. Ri
S. Ri
TST. Shigeta
T. Shigeta
MAM. Akashi
M. Akashi
YIY. Imai
Y. Imai
TKT. Komori
T. Komori

1 February 2013 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
JTJunichiro Takeuchi
Junichiro Takeuchi
HSHiroaki Suzuki
Hiroaki Suzuki
MMMaho Murata
Maho Murata
YKYasumasa Kakei
Yasumasa Kakei
SRShinshou Ri
Shinshou Ri
TKTakahide Komori
Takahide Komori

17 June 2020 in BMC Cancer
Verified
Journal Article
Open access
PDF file
THTakumi Hasegawa
Takumi Hasegawa
TITomoya Iga
Tomoya Iga
DTDaisuke Takeda
Daisuke Takeda
RARika Amano
Rika Amano
ISIzumi Saito
Izumi Saito
MAMasaya Akashi
Masaya Akashi
Background: Prognostic biomarkers provide essential information about a patient’s overall outcome. However, existing biomarkers are limited in terms of either sample collection, such as requiring tissue specimens, or the process, such as prolonged time for analysis. In view of the need for convenient and non-invasive prognostic biomarkers for oral cancer, we aimed to investigate the prognostic values of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patient survival. We also aimed to explore the associations of these ratios with the clinicopathologic characteristics of Japanese oral squamous cell carcinoma patients. Methods: This study was a non-randomized retrospective cohort study in a tertiary referral center. We included 433 patients (246 men, 187 women) who underwent radical surgery for oral cancers between January 2001 and December 2013. We evaluated various risk factors for poor prognosis including neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio with univariate and multivariate analyses. The disease-specific survival and overall survival rates of patients were compared among the factors and biomarkers. Results: In multivariable Cox proportional hazards analysis, high neutrophil-to-lymphocyte ratio (hazard ratio 2.87, 95% confidence interval 1.59–5.19, P < 0.001), moderately or poorly differentiated histology (hazard ratio 2.37, 95% confidence interval 1.32–4.25, P < 0.001), and extranodal extension (hazard ratio 1.95, 95% confidence interval 1.13–3.35, P = 0.016) were independent predictors of disease-specific survival. High neutrophil-to-lymphocyte ratio (hazard ratio 2.30, 95% confidence interval 1.42–3.72, P < 0.001), moderately or poorly differentiated (hazard ratio 1.72, 95% confidence interval 1.07–2.76, P = 0.025), and extranodal extension (hazard ratio 1.79, 95% confidence interval 1.13–2.84, P = 0.013) were independent predictors of overall survival. Conclusions: Neutrophil-to-lymphocyte ratio might be a potential independent prognostic factor in Japanese oral squamous cell carcinoma patients.

1 January 2016 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
YKYasumasa Kakei
Yasumasa Kakei
MAMasaya Akashi
Masaya Akashi
THTakumi Hasegawa
Takumi Hasegawa
TMTsutomu Minamikawa
Tsutomu Minamikawa
SUSatoshi Usami
Satoshi Usami
TKTakahide Komori
Takahide Komori

1 September 2015 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
THTakumi Hasegawa
Takumi Hasegawa
ISIzumi Saito
Izumi Saito
DTDaisuke Takeda
Daisuke Takeda
EIEiji Iwata
Eiji Iwata
NYNatsuki Yonezawa
Natsuki Yonezawa
TKTakahide Komori
Takahide Komori

1 September 2014 in Lymphatic Research and Biology
Verified
Journal Article
Closed access
YKYasumasa Kakei
Yasumasa Kakei
MAMasaya Akashi
Masaya Akashi
TSTakashi Shigeta
Takashi Shigeta
THTakumi Hasegawa
Takumi Hasegawa
TKTakahide Komori
Takahide Komori
To maintain normal function, the lymphatic endothelium is regulated by cell-cell junctions. There have been few studies of lymphatic endothelial cell junctions using standard cell biological methods. This study had two purposes: to characterize cell junctions in cultured lymphatic endothelial cells and to investigate the effects of the inflammatory cytokine TNF-α on altered cell-cell junctions. Cultured human dermal lymphatic endothelial cells (HDLEC) were immunostained with the tight junction marker, ZO-1, and adherens junction markers, VE-cadherin and PECAM-1. In TNF-α-treated HDLEC, we evaluated changes in endothelial cell junctions by immunostaining and through the use of transendothelial electrical resistance (TER). Immunofluorescence staining of HDLEC revealed heterogeneity among the endothelial cell junctions, which could be classified into continuous and discontinuous junctions. In these cell junctions, ZO-1 and VE-cadherin were co-localized. Double immunofluorescence staining revealed the broad distribution of VE-cadherin at the cell periphery, where VE-cadherin and PECAM-1 were co-localized. TNF-α treatment decreased TER, caused a predominance in the appearance of discontinuous junctions with a reduction in the broad distribution of VE-cadherin at the cell periphery in HDLEC. The results indicate a heterogeneous distribution of cell junctions in HDLEC involving continuous and discontinuous junctions. Our data also suggest that TNF-α alters the normal distribution of cell junctions and affects the endothelial barrier of cultured lymphatic endothelial cells. The broad distribution of VE-cadherin at the cell periphery may reflect the lymphatic permeability.